NCT01483378View on ClinicalTrials.gov

Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Herpes Zoster
Interventions
OTHER

Choosing to receive the vaccine

Trial Locations (2)

10016

Bellevue Hospital, New York

NYU Langone Medical Center, New York

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

NYU Langone Health

OTHER

NCT01483378 - Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital | Biotech Hunter | Biotech Hunter